BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
Stopped early · Phase 2
Conditions studied: Lupus Nephritis
In brief
The primary objective of the study is to evaluate the long-term safety and tolerability of BIIB023 in participants with lupus nephritis (LN).
Key facts
- Study ID
- NCT01930890
- Run by
- Biogen
- People needed
- 87
- Starts
- 2013-11-01
- Expected to finish
- 2016-01-01
- Last updated by the study team
- 2017-01-18
Who can join
Age: 19 and older, up to 76. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Lake Success, New York, United States
- Research Site — Columbus, Ohio, United States
- Research Site — Memphis, Tennessee, United States
- Research Site — El Paso, Texas, United States
- Research Site — Ciudad Autonoma Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina
- Research Site — San Juan, San Juan Province, Argentina
- Research Site — San Miguel de Tucumán, Tucumán Province, Argentina
- Research Site — Melbourne, Victoria, Australia
- Research Site — Leuven, Belgium
- Research Site — Liège, Belgium
- Research Site — Cuiabá, Mato Grosso, Brazil
- Research Site — Barranquilla, Colombia
- Research Site — Bogotá, Colombia
- Research Site — Medellín, Colombia
- Research Site — Pessac, Gironde, France
- Research Site — Paris, Paris Cedex 13, France
- Research Site — Shatin, Hong Kong
- Research Site — Debrecen, Hungary
- Research Site — Pisa, Pisa, Italy
- Research Site — Kuala Lumpur, Kuala Lumpur, Malaysia
- Research Site — Kuching, Sarawak, Malaysia
- Research Site — Kuala Selangor, Malaysia
- Research Site — Kuala Selangor, Malaysia
- Research Site — Cuauhtémoc, Mexico City, Mexico
- Research Site — Lima, Peru
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.